Alerje
PrivateLast Round
Early Funding
Mar 27, 2025
Est. Valuation
$2M
Total Funding Raised
$5.44M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alerje operates in Healthcare & Life Sciences and is based in Detroit, Michigan. Its latest recorded funding round was an Early Funding round in March 2025.
Alerje is a healthcare technology company that provides a digital health platform for food allergy management and oral immunotherapy (OIT) support.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Healthcare Analytics, Medical AI
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alerje Comparables
Compare Alerje with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sempresto, Inc. | 87% | |
| Aterica Health Inc. | 78% | |
| Adan Medical Innovation | 77% |
For institutional investors. Book with your work email.
Alerje Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 27, 2025 | ||||
| Grant | Sep 7, 2023 | ||||
| Seed | Jul 28, 2023 | ||||
| Grant | Jul 8, 2021 | ||||
| Convertible Debt | Mar 19, 2021 | ||||
Grant | Oct 7, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alerje Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backstage Capital | Seed, Accelerator |
| Invest Detroit | Seed |
| Quantum Medical Concepts | Convertible Debt, Seed |
| Chloe Capital | Seed |
| Accelerate Michigan Innovation Competition | Grant |
| Michigan Rise | Seed |
| Michigan Strategic Fund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 48% MoM.
- May 18, 2026
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
Alerje Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alerje's valuation, stock price, and market status.
Is Alerje a public or private company?
Alerje is a private company.
What is the current stock price of Alerje?
Alerje is a private company, so its shares have no public market price. Caplight tracks Alerje's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alerje worth (valuation)?
Alerje's valuation is estimated at $2.0M based on funding round data.
Can I buy Alerje stock?
Alerje shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alerje's last funding round?
Alerje's most recent funding round was Early Funding on March 27, 2025.
Who are the main investors in Alerje?
Key investors in Alerje include Backstage Capital.
Will Alerje IPO soon?
No public IPO plans have been announced for Alerje.
How can I track Alerje secondary market activity?
Caplight tracks bids, offers, and trades in Alerje's shares on secondary markets.